Role of the Putative Transcriptional Regulator Interleukin-33 in Endothelial Cell Activation
- Prosjektnummer
- 2009094
- Ansvarlig person
- Guttorm Haraldsen
- Institusjon
- Oslo universitetssykehus HF
- Prosjektkategori
- Postdoktorstipend
- Helsekategori
- Inflammatory and Immune System
- Forskningsaktivitet
- 1. Underpinning
The alarmin IL-33 is a notch target in quiescent endothelial cells.
Am J Pathol 2012 Sep;181(3):1099-111. Epub 2012 jul 16
PMID: 22809957
Statins affect the presentation of endothelial chemokines by targeting to multivesicular bodies.
PLoS One 2012;7(7):e40673. Epub 2012 jul 16
PMID: 22815786
Inflammation driven by tumour-specific Th1 cells protects against B-cell cancer.
Nat Commun 2011;2():240.
PMID: 21407206
Endostatin suppresses IGF-II-mediated signaling and invasion of human extravillous trophoblasts.
Endocrinology 2011 Nov;152(11):4431-42. Epub 2011 sep 20
PMID: 21933871
Inflammatory bowel disease-associated interleukin-33 is preferentially expressed in ulceration-associated myofibroblasts.
Am J Pathol 2010 Dec;177(6):2804-15. Epub 2010 okt 29
PMID: 21037074
Interleukin-33 - cytokine of dual function or novel alarmin?
Trends Immunol 2009 May;30(5):227-33. Epub 2009 apr 7
PMID: 19359217
eRapport er utarbeidet av Sølvi Lerfald og Reidar Thorstensen, Regionalt kompetansesenter for klinisk forskning, Helse Vest RHF, og videreutvikles av de fire RHF-ene i fellesskap, med støtte fra Helse Vest IKT
Alle henvendelser rettes til eRapport